Due to its multifaceted effects, the Pep_A6 vaccine, consisting of a COL6A6 peptide-KLH-conjugate and alum adjuvant, may serve as a promising vaccine formula in the future treatment of atherosclerosis. Here, COL6A6 is linked to atherosclerosis.